[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337942-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337942-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lncrnas-as-potential-prognosisdiagnosis-markers-and-factors-driving-drug-resistance-of-osteosarcoma-a-review","LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma - a review","","Osteosarcoma is a common pediatric and young-adult malignancy with poor outcomes, especially in metastatic or recurrent disease, which creates an urgent need for reliable prognostic biomarkers and actionable therapeutic targets. Long non-coding RNAs (lncRNAs) are implicated in tumor initiation, progression, treatment resistance, recurrence, and distant spread, and may regulate osteosarcoma cell growth, invasion, migration, and apoptosis. This review summarizes current evidence on how lncRNAs function in osteosarcoma development, metastasis, treatment response, and prognosis, emphasizing their clinical biomarker potential and roles in multidrug resistance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lncrnas-as-potential-prognosisdiagnosis-markers-and-factors-driving-drug-resistance-of-osteosarcoma-a-review/337942/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lncrnas-as-potential-prognosisdiagnosis-markers-and-factors-driving-drug-resistance-of-osteosarcoma-a-review/337942.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are new prognostic biomarkers needed in osteosarcoma?","Question",{"text":63,"@type":64},"Outcomes remain poor for most patients with metastatic or recurrent osteosarcoma, making it necessary to identify new and effective prognostic biomarkers and therapeutic targets.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What roles can lncRNAs play in osteosarcoma?",{"text":68,"@type":64},"Aberrant lncRNA expression is linked to tumorigenesis and may influence osteosarcoma cell growth, replication, invasion, migration, distant dissemination, and programmed cell death.",{"name":70,"@type":61,"acceptedAnswer":71},"How are lncRNAs related to drug resistance?",{"text":72,"@type":64},"LncRNAs are recognized as clinical markers and may participate in the development of multidrug resistance, acting as factors driving resistance to treatment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337942,1790144404,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","TYPE Review  \nPUBLISHED 02 July 2024  \nDOI 10.3389/fendo.2024.1415722  \nOPEN ACCESS  \nEDITED BY  \nChangjun Li,  \nCentral South University, China  \nREVIEWED BY  \nYanqing Jiang,  \nUniversity of Pennsylvania, United States Bo Jiang,  \nRice University, United States Shuang Wu,  \nThe University of Chicago, United States  \n*CORRESPONDENCE Gang Liu  \n [gangle.liu@gmail.com](gangle.liu@gmail.com)[ ](gangle.liu@gmail.com)Shuangshuang Wang  \n[wangss1023@126.com](wangss1023@126.com)  \n†These authors have contributed equally to this work  \nRECEIVED 11 April 2024  \nACCEPTED 17 June 2024  \nPUBLISHED 02 July 2024  \nCITATION  \nHu S, Han X, Liu G and Wang S (2024) LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review.  \nFront. Endocrinol. 15:1415722 .  \ndoi: 10.3389/fendo.2024.1415722  \nCOPYRIGHT  \n© 2024 Hu, Han, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nLncRNAs as potential prognosis/ diagnosis markers and factors driving drug resistance of osteosarcoma, a review  \nSiwang Hu 1†, Xuebing Han 2†, Gang Liu 2* and Shuangshuang Wang 3*  \n1The Orthopedic Center, Wenling First People’s Hospital (The Afﬁliated Wenling Hospital of Wenzhou Medical University), Wenling, China, 2 Hunan Provincial Engineering Research Center of Applied Microbial Resources Development for Livestock and Poultry, College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China, 3 Department of Cardiology, Wenling First People’s Hospital (The Afﬁliated Wenling Hospital of Wenzhou Medical University),  \nWenling, China  \nOsteosarcoma is a common malignancy that often occurs in children, teenagers and young adults. Although the treatment strategy has improved, the results are still poor for most patients with metastatic or recurrent osteosarcomas . Therefore, it is necessary to identify new and effective prognostic biomarkers and therapeutic targets for diseases. Human genomes contain lncRNAs, transcripts with limited or insufﬁcient capacity to encode proteins. They have been implicated in tumorigenesis, particularly regarding the onset, advancement, resistance to treatment, recurrence and remote dissemination of malignancies. Aberrant lncRNA expression in osteosarcomas has been reported by numerous researchers; lncRNAs have the potential to exhibit either oncogenic or tumorsuppressing behaviors and thus, to govern the advancement of this skeletal cancer. They are suspected to inﬂuence osteosarcoma cell growth, replication, invasion, migration, remote dissemination and programmed cell death. Additionally, they have been recognized as clinical markers, and may participate in the development of multidrug resistance. Therefore, the study of lncRNAs in the growth, metastasis, treatment and prognosis of osteosarcoma is very important for the active prevention and treatment of osteosarcoma. Consequently, this work reviews the functions of lncRNAs.  \nKEYWORDS  \nosteosarcoma, lncRNA, cancer cell, biomarkers, indicators  \nFrontiers in Endocrinology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction to the treatment and research of osteosarcoma  \nOsteosarcoma, which originates from mesenchymal cells, is oneof the most frequently occurring bone tumor. It is responsible for asigniﬁcant proportion of child and teenage mortalities occurring due to malignancy. Typical histological appearances of osteosarcoma include spindle cells and the abnormal generation of osteoid (1) . The long-term survival rate of individuals who present without remote tumor dissemination is approximately 80% . Conversel","cbCairBg8IiM2P8H","https://ap.wps.com/l/cbCairBg8IiM2P8H","pdf",1842258,18,"English","# Introduction to the treatment and research of osteosarcoma\n## Clinical challenge and need for biomarkers\n## Biological roles of lncRNAs in osteosarcoma\n## Therapeutic strategies and limitations","[{\"question\":\"Why are new prognostic biomarkers needed in osteosarcoma?\",\"answer\":\"Outcomes remain poor for most patients with metastatic or recurrent osteosarcoma, making it necessary to identify new and effective prognostic biomarkers and therapeutic targets.\"},{\"question\":\"What roles can lncRNAs play in osteosarcoma?\",\"answer\":\"Aberrant lncRNA expression is linked to tumorigenesis and may influence osteosarcoma cell growth, replication, invasion, migration, distant dissemination, and programmed cell death.\"},{\"question\":\"How are lncRNAs related to drug resistance?\",\"answer\":\"LncRNAs are recognized as clinical markers and may participate in the development of multidrug resistance, acting as factors driving resistance to treatment.\"}]","LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma - a review | PDF",1790021267,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39e3bc87debf5f66fb91ff59787097f7.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e024286cc9fce41ed51a8166ce9b3d8d.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46038ebefdda0b91b904d25e187c0d38.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36cb9a00c73f9da6645235f2075cdd26.webp",980,1385]